Objective: Psychological distress is common in cancer patients, and awareness of its indicators is essential. We aimed to assess the prevalence of psychological distress and to identify problems indicative of high distress.
| INTRODUCTION
Numerous studies have shown cancer diagnosis and multimodal treatments to be associated with an increased risk of high emotional distress and mental comorbidity. [1] [2] [3] [4] [5] [6] Treatment side effects and high levels of physical symptom burden negatively affect many aspects of patients' quality of life. Most patients report cancer-related fatigue, 7 pain, 8 and a variety of functional disabilities including impaired mobility and cognition 9, 10 that impede survivors' private, social, and work life as well as many activities of daily living. 11 High rates of psychological distress, anxiety, and depression have been found by using self-report or screening measures. 1, [12] [13] [14] [15] [16] Thus, emotional distress is common in patients and can be seen as part of the psychological adaptation process to managing the diagnosis of cancer as a stressful life event. Nonetheless, high levels of distress may still require clinical attention and individualized professional support. High levels of emotional distress have been associated not only with high physical symptom burden but also with significantly lower quality of life, satisfaction with care, and treatment adherence. [17] [18] [19] [20] It is a primary challenge in cancer care to identify patients with high distress and those in need of psychological support and to facilitate timely and low-threshold access to psychooncological care.
Although there is some controversy over the effectiveness of screening tools for psychological distress, [21] [22] [23] [24] [25] 
| METHODS
The full study protocol to this cross-sectional multicenter study has been published previously. 31 We used a proportional stratified random sample based on the nationwide incidence of all cancer diagnoses in Germany. 31 Eligible patients were asked to complete a set of validated self-report measures.
A subsample of study participants also took part in a structured clinical interview, the results of which are presented elsewhere. We measured psychological distress by using the validated German version of the NCCN DT. 6 The DT is a valid, reliable, and widely used screening measure. 34 The screening contains a single-item visual analogue scale ranging from 0 ("no distress") to 10 ("extreme distress") to 
| Statistical analysis
Differences in distress by sociodemographic and medical characteristics were compared with one-way ANOVA. To identify specific problems that were most strongly associated with the remaining problems, we conducted monothetic analysis (MONA), a method of hierarchical clustering, using R. 35 The first MONA included all 34 items; the second analysis included only the 20 items covering physical problems, as these might appear particularly often in cancer care. The MONA algorithm identifies the variable from a list, which has the maximal association with all other variables on the same list. The list is then divided into 2 clusters based on this variable. This is repeated for each new cluster, resulting in a hierarchical ranking. 36, 37 Thus, the top-ranked items are those which are most predictive of the other items on the list.
In a second step, we analyzed mean levels of distress (DT) and prevalence of high distress (cutoff ≥ 5) 6 for patients who reported 1, 2, or all 3 of the top-ranked problems.
3 | RESULTS
| Participants
Out of 5889 eligible cancer patients, 4020 participated in the study, leading to a final sample of 3724 patients with complete data on psychological distress. Most frequent reasons for nonparticipation were "not interested" (n = 993, 55% of nonparticipants) and "too burdensome" (n = 588, 33%). As reported previously, 32 nonresponder analyses revealed that study participants were younger (P < .001), more educated (P < .001), and more likely to be recruited from a cancer rehabilitation center (P < .001) than nonparticipants.
Demographic and medical characteristics as well as levels of distress are presented in Table 1 . Mean age was 58.3 years (SD = 11.3 years), and mean time since current cancer diagnosis was 13.5 months (SD = 24.9). Patients whose tumor stage could not be determined were mostly patients with unconfirmed metastases (stage III or IV). *Different sample size due to missing data; P values based on one-way ANOVA.
| Prevalence of distress
We found that 52% of the total sample reported clinically significant levels of psychosocial distress (≥5 on the visual analogue scale). Our one-way ANOVA revealed that the levels of distress varied significantly for sociodemographic and medical groups. The highest levels of distress were found in women, patients who were 60 or older, unemployed, had cancers of the female genital organs or pancreatic cancer, or were in advanced stages of the disease ( The most prevalent problems were fatigue (56%), sleep problems (51%), and problems getting around (47%; Table 2 ). On average, patients had 8 (SD = 5.6) problems (range 0-29). Women endorsed 26 of the 36 physical and psychosocial problems significantly more frequently than men did. Men, on the other hand, more frequently reported sexual problems as well as changes in urination (P < .05).
We found no significant difference in the number of problems among inpatient care, outpatient care, and rehabilitative settings (P = .88). The total number of problems was significantly associated with higher distress (r = 0.56; P < .001). Table 3 shows the results of a cluster analysis using all 34 DT items covering practical, emotional, physical, family, and spiritual problems.
| Problems indicative of other problems and high distress
We identified 2 physical problems (sleep problems and fatigue) and 1 emotional problem (sadness) as most strongly associated with psychological distress on the visual analogue scale.
Patients with any one of these problems had higher distress scores (M = 3.5-4.4) than patients that had none of the 3 problems (M = 2.8).
Almost two-thirds (62.2%) of patients with any 2 out of the 3 problems showed distress scores above the clinical cutoff (M = 5.2). When patients reported all 3 problems, the distress score rose to M = 6.4
and at least 4 out of 5 patients (81.4%) with these problems were highly distressed. Men showed the same ranking of problems as the total sample. When analyzing only women, fatigue and sadness remained but worrying proved to be more strongly associated with distress than sleep problems compared with the total sample.
When analyzing only the 20 physical problems, the following 3 problems were most predictive of the other problems on the list:
indigestion, problems getting around, and fatigue (Table 3) 
| DISCUSSION
In this large, representative sample across all major tumor entities, 52%
of patients were found to have high psychological distress with the highest levels found in patients with female genital cancers or pancreatic cancer. The lowest level of distress was found in patients with prostate cancer.
Our results suggest a lower prevalence of distress than Meggiolaro and colleagues (60%) 16 but a higher prevalence than Kendall and colleagues (33%), 38 using the same instrument (DT) in similar populations.
Discrepancies in distress could be caused by different sample compositions in sex, age, included cancer types, and treatment stages. In particular, our study used a random epidemiological sample, while some other studies may have used a self-selection of patients seeking psychosocial support. We also found higher levels of distress compared with an early study by Zabora and colleagues, 1 who found high distress in 35% of the patients, using the Brief Symptom Inventory. However, prevalence estimates derived from different instruments are difficult to compare.
Interestingly, in our sample, patients with female genital cancers had the highest levels of distress, whereas in Zabora's study, this patient group was found to have the lowest distress rate. This is even more surprising as our sample had fewer patients with more severe genital cancers such as ovarian cancer (40% vs 47% out of women with genital tumors). Compared with a study by Carlson and colleagues, we found similar distress rates for the total sample but slightly higher rates in breast cancer patients and considerably lower distress rates in lung cancer patients.
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It is also relevant to recognize that 58% of patients with pancreatic cancer were highly distressed but were found to have the lowest prevalence of mental disorders (20%) in a subsample of this study. 32 Future research should address the issue to what extent distress as assessed by the DT is linked to mental disorders.
The differences in cancer site may, in part, be due to differences in sex distribution. We found significantly higher levels of distress and frequency of reported problems in women compared with those in men, which is in accordance with other studies in cancer populations [40] [41] [42] and in the general population, 43, 44 although the causes of these gender differences in prevalence rates are currently not well understood. Possible explanations include response bias, biological, In women alone, the results of the overall monothetic analysis could not be reproduced. Instead of sleep problems, worrying was more indicative of distress in women. This could be due to gender differences in coping, which would suggest 3 major explanations:
First, women may admit emotional problems more easily as they were socialized to be more expressive (methodological-artifact argument). Second, women may generally face more stressors (or more severe stressors) than men do (stress-exposure argument).
Third, women may lack appropriate coping resources for handling the stressors they experience (vulnerability argument). It is unlikely, however, that women's responses are biased by social desirability of reporting problems, 47 even though men's responses might be. Because worrying may lead to sleeplessness, it is plausible that women and men may express similar concerns by using different words.
We further analyzed a subset of only physical problems for 2 main These problems thus hold the potential of functioning as "red flags"
for identifying highly distressed patients in oncological care settings, especially when occurring in combination.
There are several possible explanations for why these problems were associated with particularly high levels of distress. It is likely that these are problems that represent particularly strong limitations in daily living ability and lead to social isolation or high dependence on others. Future research could investigate to what extent these problems cause high distress, which mediators are involved, and how reducing these problems can lead to lower levels of distress.
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| Study limitations
Our sample was slightly biased toward younger age, higher school education, and rehabilitation setting. 32 In addition, the MONA we used to identify problems that best represent the remaining problems is a relatively fresh approach to the analysis of symptom clusters related to distress in cancer patients. Because our analysis does not guarantee that the problems identified represent the most distressing symptoms in general but is limited to the pool of problems from which they were chosen, we also aim to pursue further studies on this highly relevant subject to compare and replicate our results by using broader sets of potential indicators. In addition, the cross-sectional design did not permit inferences on causality. The age-limited inclusion criteria do not allow generalization to very young or old cancer patients.
Distress levels can be transient, and repeated assessment at appropriate intervals such as changes in disease status plus a full mental status assessment in those with high levels of distress is the most reliable method of ascertaining a clinically important psychological problem. 25, 51 Furthermore, more research is needed on the performance of the DT against "gold standard" clinical interview.
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| Clinical implications and conclusions
Our results provide crucial insights for health-care professionals regarding the large number of patients facing a high psychosocial and physical symptom burden. In the spirit of personalized medicine, indicators of distress and therefore need of psychosocial support should be taken into account during routine inpatient and outpatient cancer care. We therefore identified the core problems that can indicate high distress and are easy and quick to assess. We hope that this represents a significant step toward better detection and treatment of psychosocial comorbidity in cancer patients.
